Cellebrite DI (CLBT) Invested Capital (2019 - 2025)

Cellebrite DI's Invested Capital history runs 7 years deep, the most recent figure standing at $484.3 million for Q4 2025.

• In Q4 2025, Invested Capital rose 44.13% year-over-year to $484.3 million; the TTM figure through Dec 2025 stood at $484.3 million (up 44.13% YoY), while the FY2025 annual figure was $484.3 million, up 44.13% from the prior year.
• Invested Capital was $484.3 million for Q4 2025 at Cellebrite DI, up from $447.7 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $484.3 million in Q4 2025 to a low of -$73.3 million in Q4 2021.
• Historically, Invested Capital has averaged $173.5 million across 5 years, with a median of $56.6 million in 2022.
• The sharpest annual moves came in 2021 and 2025: Invested Capital sank 214.96% in 2021, then jumped 1461.09% in 2025.
• A 5-year view of Invested Capital shows it stood at -$73.3 million in 2021, then jumped by 200.71% to $73.9 million in 2022, then sank by 53.68% to $34.2 million in 2023, then soared by 882.17% to $336.0 million in 2024, then soared by 44.13% to $484.3 million in 2025.
• The last three Invested Capital figures came in at $484.3 million (Q4 2025), $447.7 million (Q3 2025), and $408.4 million (Q2 2025), per Business Quant data.